首页 | 本学科首页   官方微博 | 高级检索  
     

肝动脉塞栓化疗治疗原发性肝癌
引用本文:曾庆祉,李毅刚,张国平. 肝动脉塞栓化疗治疗原发性肝癌[J]. 河北医学, 2003, 9(4): 312-314
作者姓名:曾庆祉  李毅刚  张国平
作者单位:广东省韶关市粤北人民医院肿瘤内科,广东,韶关,512025
摘    要:目的:研究肝动脉栓塞化疗治疗原发性肝癌的效果。方法:对380例肝癌患者实行肝动脉栓塞化疗。采用Sedinger方法经股动脉穿刺插管,药物选用ADM,MMC,5—Fu,DDP联合化疗。结果:本组半年、1年;2年、3年生存率分别为:78.3%、37.4%、19.6%和7.3%,复查有明显肿块缩小(30%以上)的患者达83.3%(175/210),缩小30%以下或无变化者23例,占11%。结论:肝动脉栓塞化疗对原发性肝癌有明显效果。

关 键 词:肝动脉栓塞化疗 治疗 原发性肝癌 Sedinger方法
文章编号:1006-6233(2003)04-0312-03

Hepaticarterial chemombilization treatment for hepatocellular carcinoma
ZENG Qing-zhi,LI Yi-gang,ZHANG Guo-ping. Hepaticarterial chemombilization treatment for hepatocellular carcinoma[J]. Hebei Medicine, 2003, 9(4): 312-314
Authors:ZENG Qing-zhi  LI Yi-gang  ZHANG Guo-ping
Abstract:Objective: To study the effect of hepaticarterial chemombilization (HACE) treating for hepatocellular carcinoma (HCC). Methods: 380 cases with HCC treated by HACE. We used seldinger method to puncture through femoral artery with ADM, MMC, 5-Fu combined DDP. Results: The survival rate of half year, 1year, 2 year, 3 year is following: 78.3%, 37.4%, 19.6% and 7.3%. Patients with tumor shrinking obviously (above 30%) after reexamination were 83.3% (175/210), tumor shrinking under 30% and no changes were 11% (23/210). Conclusion: HACE has effect on HCC.
Keywords:HCC  HACE  Treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号